I am going to be speaking at a conference Saturday, September 12, 2009 at the Medical School of Lublin in Poland. At this conference, I am going to detail how Creighton Model FertilityCareTM System, which is a standardized charting record of biomarkers (such as bleeding, mucus discharge, and dry days) related to the menstrual and fertility cycles, is used to assess normal and abnormal gynecologic and reproductive function. It is essential that women keep good gynecologic charting records. Because the Creighton Model System is standardized, objective and prospective, it provides very accurate information. Thus, as one uses this system as a natural means of regulating fertility, one also uses it as a women’s health maintenance system. It can, therefore, indicate with a reasonable degree of likelihood that the possibility of certain gynecologic conditions exists.
Then, this Creighton Model information is used wtih the new health science of NaProTECHNOLOGY, which devotes its medical, surgical and allied health energies and attention to cooperating with the natural procreative mechanisms and functions. When these mechanisms are functioning abnormally, NaProTECHNOLOGY cooperates with the procreative mechanisms in evaluating the condition and producing a form of treatment which corrects the condition, maintains the human ecology and sustains the procreative potential.